Trademark: 87580599
Status Date
Tuesday, August 31, 2021
Registration Number
6471194
Registration Date
Tuesday, August 31, 2021
Filing Date
Wednesday, August 23, 2017
Published for Opposition
Tuesday, May 8, 2018
44 Medical diagnostic testing services in the field of human disease and human medical conditions; medical testing for diagnostic or treatment purposes; providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services and medical testing for diagnostic or treatment purposes; providing an Internet website portal featuring medical information in the field of human disease, and human medical conditions, medical diagnostic testing services, medical testing for diagnostic or treatment purposes; providing cloud-based medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services, and medical testing for diagnostic or treatment purposes; medical testing for the detection of cancer; medical testing for the detection of genetic information pertaining to human disease; Medical diagnostic testing to aid in diagnosis, prognosis and therapy selection; oncology reference laboratory services
42 Genetic mapping for scientific purposes; gene sequencing; molecular sequencing; cancer study and analysis; clinical study and testing of cells; medical and scientific research information in the field of gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells; scientific research in the field of gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells, and cancer; providing information to others in the fields of oncology, pathology and gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells scientific testing and research services and clinical scientific testing; providing an internet website portal featuring gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells; scientific and medical research information in the fields of scientific testing and research services, medical research services, and clinical scientific testing; providing cloud-based scientific and medical research information to others in the field of scientific testing and research services, medical research services, and clinical scientific testing; providing temporary use of online non-downloadable software for analysis of medical test results; temporary use of online non-downloadable software for enhancement of analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information and pertaining to such testing and analysis; software as a service (SAAS) services featuring software for analysis of medical test results; non-downloadable computer software for enhancement of analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information pertaining to testing and analysis; providing medical research and scientific research information in the field of oncology ; genetic testing, rna testing and sequencing; scientific testing and research services in the field of human disease and human medical conditions; providing medical research services in the field of human disease and human medical conditions; providing clinical scientific testing services and medical research and testing in the field of human disease and human medical conditions; clinical laboratory services, oncology reference laboratory services, providing information, interactive information, and reports, to others in the field of pathology, diagnostic testing, oncology testing; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; medical and scientific research, namely, conducting clinical trials for others; conducting research and clinical trials for others relating to medical devices and pharmaceuticals
NEO GENOMICS EUROPE
"EUROPE"
Feb 1, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 1, 2023
Teas Change Of Correspondence Received
Feb 1, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 1, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 1, 2023
Teas Change Of Owner Address Received
Nov 10, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 10, 2022
Teas Change Of Correspondence Received
Nov 10, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 10, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 10, 2022
Teas Change Of Owner Address Received
Jun 13, 2022
Teas Change Of Correspondence Received
Jun 13, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 13, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 31, 2021
Registered-Principal Register
Jul 29, 2021
Notice Of Acceptance Of Statement Of Use E-Mailed
Jul 28, 2021
Allowed Principal Register - Sou Accepted
Jul 20, 2021
Teas/Email Correspondence Entered
Jul 19, 2021
Correspondence Received In Law Office
Jul 19, 2021
Teas Response To Office Action Received
Jul 19, 2021
Notification Of Non-Final Action E-Mailed
Jul 19, 2021
Non-Final Action E-Mailed
Jul 19, 2021
Su - Non-Final Action - Written
Jul 8, 2021
Statement Of Use Processing Complete
Jul 1, 2021
Use Amendment Filed
Jul 1, 2021
Teas Statement Of Use Received
Jul 1, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 1, 2021
Teas Change Of Correspondence Received
Jul 1, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 1, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 1, 2021
Teas Change Of Owner Address Received
Dec 18, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 17, 2020
Sou Extension 5 Granted
Dec 14, 2020
Sou Extension 5 Filed
Dec 14, 2020
Teas Extension Received
Dec 14, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Dec 14, 2020
Teas Change Of Correspondence Received
Dec 14, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 14, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 14, 2020
Teas Change Of Owner Address Received
Jul 23, 2020
Assigned To Examiner
Jul 7, 2020
Notice Of Approval Of Extension Request E-Mailed
Jul 6, 2020
Sou Extension 4 Granted
Jul 1, 2020
Sou Extension 4 Filed
Jul 1, 2020
Teas Extension Received
Jul 1, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 1, 2020
Teas Change Of Correspondence Received
Jul 1, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 1, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 1, 2020
Teas Change Of Owner Address Received
Dec 21, 2019
Notice Of Approval Of Extension Request E-Mailed
Dec 20, 2019
Sou Extension 3 Granted
Dec 16, 2019
Sou Extension 3 Filed
Dec 20, 2019
Case Assigned To Intent To Use Paralegal
Dec 16, 2019
Teas Extension Received
Jul 3, 2019
Assignment Of Ownership Not Updated Automatically
Jun 27, 2019
Notice Of Approval Of Extension Request E-Mailed
Jun 25, 2019
Sou Extension 2 Granted
Jun 25, 2019
Sou Extension 2 Filed
Jun 25, 2019
Teas Extension Received
Dec 25, 2018
Notice Of Approval Of Extension Request E-Mailed
Dec 21, 2018
Sou Extension 1 Granted
Dec 21, 2018
Sou Extension 1 Filed
Dec 21, 2018
Teas Extension Received
Jul 3, 2018
Noa E-Mailed - Sou Required From Applicant
May 8, 2018
Official Gazette Publication Confirmation E-Mailed
May 8, 2018
Published For Opposition
Apr 18, 2018
Notification Of Notice Of Publication E-Mailed
Mar 29, 2018
Approved For Pub - Principal Register
Mar 7, 2018
Teas/Email Correspondence Entered
Mar 7, 2018
Correspondence Received In Law Office
Mar 5, 2018
Teas Response To Office Action Received
Dec 1, 2017
Notification Of Non-Final Action E-Mailed
Dec 1, 2017
Non-Final Action E-Mailed
Dec 1, 2017
Non-Final Action Written
Nov 29, 2017
Assigned To Examiner
Sep 11, 2017
Preliminary/Voluntary Amendment - Entered
Sep 10, 2017
Assigned To Lie
Aug 29, 2017
New Application Office Supplied Data Entered
Aug 28, 2017
Teas Voluntary Amendment Received
Aug 26, 2017
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
